IT
Insignis Therapeutics Inc.
SEC filingOther · North Haven, CT
Amount raised$6Msold at filing
Total offering$8.5M$2.5M still open
Investors in the raise4count reported to the SEC
FiledAug 5, 2026first sale Jun 11, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Mingbao ZhangExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.